Developing novel ways to refine, reduce and replace the use of animals in research and enhance animal and human health.
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their ...
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
Taxidermied, locked behind plexiglass and spinning slowly on a wooden dais in the National Museum of Scotland in Edinburgh, UK, the world’s most famous ewe remains a public spectacle three decades ...
Opinion
1dOpinion
The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones
Editorial: Polling shows that the public supports this new technology, but the conversation must move beyond simple questions of safety ...
Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...
In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...
Biomedical Engineering Is the Backbone of Modern Medical Advancement and the Biomedical Engineering Society (BMES) is ...
Morning Overview on MSN
A single gene-editing infusion cut severe swelling attacks by 87 percent in a trial
People living with hereditary angioedema, a rare genetic condition that triggers sudden, painful swelling of the face, throat ...
CRISPR Therapeutics wins FDA pediatric approval for Casgevy, boosting market potential and pipeline upside despite slow uptake. Click here to read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results